Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov:202:115108.
doi: 10.1016/j.addr.2023.115108. Epub 2023 Sep 27.

Revolutionizing drug formulation development: The increasing impact of machine learning

Affiliations
Review

Revolutionizing drug formulation development: The increasing impact of machine learning

Zeqing Bao et al. Adv Drug Deliv Rev. 2023 Nov.

Abstract

Over the past few years, the adoption of machine learning (ML) techniques has rapidly expanded across many fields of research including formulation science. At the same time, the use of lipid nanoparticles to enable the successful delivery of mRNA vaccines in the recent COVID-19 pandemic demonstrated the impact of formulation science. Yet, the design of advanced pharmaceutical formulations is non-trivial and primarily relies on costly and time-consuming wet-lab experimentation. In 2021, our group published a review article focused on the use of ML as a means to accelerate drug formulation development. Since then, the field has witnessed significant growth and progress, reflected by an increasing number of studies published in this area. This updated review summarizes the current state of ML directed drug formulation development, introduces advanced ML techniques that have been implemented in formulation design and shares the progress on making self-driving laboratories a reality. Furthermore, this review highlights several future applications of ML yet to be fully exploited to advance drug formulation research and development.

Keywords: Active learning; Drug delivery; Drug development; Machine learning.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Z.B., R.J.H., A.A.-G., P.B., and C.A. are founding members of a new company, 15073383 Canada Inc. A.A.-G is a founding member of Kebotix, Inc.

Publication types

LinkOut - more resources